The 2026 Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for developing optogenetics. This revolutionary technique uses light and genetic modification to control individual nerve cells with millisecond precision. Originating from discoveries of light-sensitive algal proteins in the 1990s, optogenetics now allows scientists to map brain circuits and study complex disorders like Alzheimer's, with clinical trials already underway to restore vision.
The 2026 Nobel Prize in medicine
- ▪Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Physiology or Medicine on October 5, 2026, for their discoveries concerning light-gated ion channels and optogenetics
- ▪Karl Deisseroth, Peter Hegemann, and Georg Nagel, the three 2026 Nobel laureates in medicine, will share a prize sum of 12 million Swedish crowns, equivalent to approximately $1.2 million
Discovery of channelrhodopsin
- ▪In the early 1990s, Peter Hegemann investigated how the green alga Chlamydomonas reinhardtii reacts to light, hypothesizing that a single protein captured light and acted as an ion channel
- ▪Georg Nagel tested Peter Hegemann's hypothesis by injecting Chlamydomonas genes into frog eggs, discovering the light-sensitive ion channel protein channelrhodopsin-2
- ▪In 2003, Georg Nagel and Peter Hegemann published findings showing that channelrhodopsin could be introduced into human and hamster cells to generate electrical impulses using light
Development of optogenetics
- ▪The technique of using light combined with genetic modifications to switch individual nerve cells in a living brain on or off was named optogenetics in 2006
- ▪In 2005, Karl Deisseroth and his colleagues at Stanford University successfully introduced the gene for channelrhodopsin into rodent nerve cells, demonstrating that blue light could trigger nerve signals
Research applications of optogenetics
- ▪Karl Deisseroth used optogenetics in animal models to control mouse whisker movements by activating motor cortex nerve cells and to wake sleeping mice by stimulating wakefulness-controlling neurons
- ▪Optogenetics allows researchers to map the brain and study how individual nerve cells and circuits shape memories, feelings, behaviors, and bodily functions
- ▪Researchers are using optogenetics in animal models to study the cellular mechanisms of schizophrenia, Alzheimer's disease, Parkinson's disease, epilepsy, depression, and addiction
Clinical and therapeutic applications
- ▪Clinical trials are applying optogenetics to restore partial vision in patients blinded by retinitis pigmentosa by inserting light-sensitive proteins into remaining healthy retinal cells
- ▪The biotechnology companies MapLight and Nanoscope Therapeutics are developing optogenetic-based therapies for autism spectrum disorder and retinitis pigmentosa, respectively
Debatable claims
- ▪Optogenetics is safe enough for direct therapeutic applications in humans
- ▪Manipulating animal behavior through optogenetics is justified by its medical insights
- ▪Using optogenetics to alter human memories and emotions is ethically justifiable
- ▪Optogenetics is a more promising path for treating brain disorders than traditional pharmaceuticals
Story comments
Loading comments…